National Health Investors (NHI) Common Equity (2009 - 2026)

National Health Investors has reported Common Equity for 18 years, with the latest figure at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 5.56% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 5.56% YoY), and the FY2025 full-year result was $1.5 billion, up 11.22% from the prior year.
• Common Equity for Q1 2026 stood at $1.5 billion, down from $1.5 billion in the prior quarter.
• The five-year high for Common Equity was $1.5 billion in Q4 2025, with the low at $1.2 billion in Q3 2024.
• Historically, Common Equity has averaged $1.4 billion across 5 years, with a median of $1.3 billion in 2022.
• Annual changes were most pronounced in 2022 — Common Equity slipped 15.62% — and 2025, when it climbed 20.27%.
• National Health Investors' Common Equity stood at $1.3 billion in 2022, then decreased by 1.23% to $1.3 billion in 2023, then rose by 8.78% to $1.4 billion in 2024, then climbed by 11.22% to $1.5 billion in 2025, then fell by 0.98% to $1.5 billion in 2026.
• The last three Common Equity figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.